Yanyan Han
Company: HRYZ Biotech Co.
Job title: CSO
Seminars:
Case Study: Bridging the Gap: Navigating the Translation to Clinic in TCR-T Development 1:30 pm
Key strategies and considerations for translating TCR-T therapies from preclinical development to clinical applications The FIH study of an HLA-class II restricted HPV18 E7 specific TCR cloned from a long-term surviving cervical cancer patient Beside affinity, what did we learn from TCR-T development? Deciding on a preclinical model and data packageRead more
day: Conference Day One
Panel: Navigating Speed & Efficacy: Fast-Tracking TCR Therapy to Clinical Trials with Uncompromised Results 12:00 pm
Discuss streamlined preclinical strategies, such as advanced in vitro models or computational analyses, enabling efficient candidate selection and validation, expediting the transition from bench to bedside Explore approaches in navigating regulatory processes efficiently without compromising safety or efficacy, ensuring compliance while expediting clinical trial initiation Highlight adaptive trial designs or novel methodologies employed in clinical…Read more
day: DAY ONE TRACK 1 B
Case Study: Bridging the Gap: Navigating the Translation to Clinic in TCR-T Development 11:30 am
Key strategies and considerations for translating TCR-T therapies from preclinical development to clinical applications The FIH study of an HLA-class II restricted HPV18 E7 specific TCR cloned from a long-term surviving cervical cancer patient Beside affinity, what did we learn from TCR-T development? Deciding on a preclinical model and data packageRead more
day: DAY ONE TRACK 1 B